| F131125A |
デュロキセチンとその分解物 |
医薬品、代謝物 |
Amino alcohol (3-Methylamino-1-thiophen-2-yl-propan-1-ol)
Para isomer (4-(3-Methylamino-1-shiophen-2-yl-propyl)-naphthalen-1-ol))
ortho isomer (2-(3-Methylamino-1-thiophen-2-yl-propyl)-naphthalen-1-ol)
Duloxetine hydrochloride
α-Naphthol |
YMC-Triart C18 |
TA12S05-1503WT |
63,000 |
DEMO |
| F131125A |
デュロキセチンとその分解物 |
医薬品、代謝物 |
Amino alcohol (3-Methylamino-1-thiophen-2-yl-propan-1-ol)
Para isomer (4-(3-Methylamino-1-shiophen-2-yl-propyl)-naphthalen-1-ol))
ortho isomer (2-(3-Methylamino-1-thiophen-2-yl-propyl)-naphthalen-1-ol)
Duloxetine hydrochloride
α-Naphthol |
YMC-Triart C18 |
TA12SP9-0502WT |
86,000 |
DEMO |
| U110301A |
パロキセチン塩酸塩(USP 32nd;Assay) |
医薬品、代謝物 |
Paroxetine related compound B
Paroxetine hydrochloride |
YMC-Pack TMS |
TM12S05-2546WT |
88,000 |
DEMO |
| U110301B |
パロキセチン塩酸塩(EP 6.0;Assay) |
医薬品、代謝物 |
Paroxetine related compound B
Paroxetine hydrochloride |
YMC-Pack TMS |
TM12S05-2546WT |
88,000 |
DEMO |
| U110215A |
パロキセチン錠(USP 32nd) |
医薬品、代謝物 |
Paroxetine hydrochloride |
YMC-Pack Pro C8 |
OS12S03-H546WT |
61,000 |
DEMO |
| H150501A |
モンテルカストナトリウム錠(JP原案;Dissolution) |
医薬品、代謝物 |
Montelukast sodium |
YMC-Pack Ph |
PH12S05-1003WT |
70,000 |
DEMO |
| H150501B |
モンテルカストナトリウム錠 (USP 40th;Dissolution) |
医薬品、代謝物 |
Montelukast sodium |
YMC-Pack Ph |
PH12S05-1003WT |
70,000 |
DEMO |
| H150501C |
モンテルカストナトリウム顆粒 (USP 40th;Dissolution) |
医薬品、代謝物 |
Montelukast sodium |
YMC-Pack Ph |
PH12S05-1003WT |
70,000 |
DEMO |
| F170222A |
イプリフラボン |
医薬品、代謝物 |
Ipriflavone |
YMC-Triart C8 |
TO12S05-1504WT |
63,000 |
DEMO |
| J100407A |
ベンゾジアゼピン系薬(トリアゾラム, エチゾラム) - LC/MS |
医薬品、代謝物 |
Triazolam
Etizolam |
YMC-Triart C18 |
TA12S05-0502WT |
60,000 |
DEMO |
| O950627B |
抗精神病薬 |
医薬品、代謝物 |
Perphenazine
Prochlorperazine maleate
Promazine hydrochloride
Fluphenazine hydrochloride
Trifluoperazine hydrochloride
Ethopropazine hydrochloride (Profenamine hydrochloride)
Chlorpromazine hydrochloride
Thioridazine hydrochloride |
J'sphere ODS-H80 |
JH08S04-L546WT |
57,000 |
DEMO |
| H140204A |
アリピプラゾール(USP 36th ; Assay,Impurities) |
医薬品、代謝物 |
Aripiprazole
Aripiprazole related compound F |
YMC-Pack ODS-A |
AA12S03-1046WT |
66,000 |
DEMO |
| S960723A |
抗てんかん薬 |
医薬品、代謝物 |
Ethosuximide
Primidone
Phenobarbital sodium salt
Phenytoin
Carbamazepine |
YMC-Pack Pro C18 |
AS12S05-1546WT |
63,000 |
DEMO |
| F100621A |
バルビツール酸系薬物 |
医薬品、代謝物 |
Barbital
Phenobarbital
Hexobarbital
Pentobarbital
Secobarbital |
YMC-Triart C18 |
TA12S05-0502WT |
60,000 |
DEMO |
| F100621B |
血清中のバルビツール酸系薬物 |
医薬品、代謝物 |
Barbital
Phenobarbital
Hexobarbital
Pentobarbital
Secobarbital |
YMC-Triart C18 |
TA12S05-0502WT |
60,000 |
DEMO |
| U110611A |
リスペリドン (JP 16th;Related substances) |
医薬品、代謝物 |
Risperidone |
YMC-Triart C18 |
TA12S03-1046WT |
69,000 |
DEMO |
| U110604A |
リスペリドン錠、細粒、内服液 (JP 16th;Assay) |
医薬品、代謝物 |
Risperidone |
YMC-Pack ODS-A |
AA30S03-1503WT |
86,000 |
DEMO |
| U110604B |
リスペリドン錠、細粒、内服液 (JP 16th;Related Substances) |
医薬品、代謝物 |
Risperidone |
YMC-Pack ODS-A |
AA30S03-1503WT |
86,000 |
DEMO |
| U110604C |
リスペリドン錠、細粒 (JP 16th;Dissolution) |
医薬品、代謝物 |
Risperidone |
YMC-Triart C18 |
TA12S05-1546WT |
63,000 |
DEMO |
| P130703A |
クエチアピンフマル酸塩(JP; Assay,Related substances i) |
医薬品、代謝物 |
Quetiapine fumarate |
YMCbasic |
BA99S05-2546WT |
102,000 |
DEMO |